South Wales, June 12 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "liquistal" on May 28. The details about the trademark application no. UK00004393854 published in the journal no. 2026/024 (June 12).
With Withers & Rogers LLP as representative, Chong Kun Dang Pharmaceutical Corp. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations; filled syringes for medical purposes [containing pharmaceuticals]; pharmaceutical preparations for the treatment of pubertas praecox; pharmaceutical preparations for the treatment of cancer of the prostate gland; pharmaceutical preparations for the treatment of breast cancer prior to menopause; pharmaceutical preparations for the treatment of hypermenorrhea; pharmaceutical preparations for the treatment of endometriosis; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the suppression of hormones; pharmaceutical preparations, namely, hormones for medical purposes.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004393854
Disclaimer: Curated by HT Syndication.
